These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 201668)
1. Properties of the plasma very low and low density lipoproteins in Tangier disease. Heinen RJ; Herbert PN; Fredrickson DS J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668 [TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Wang CS; Alaupovic P; Gregg RE; Brewer HB Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493 [TBL] [Abstract][Full Text] [Related]
3. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man. Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553 [TBL] [Abstract][Full Text] [Related]
4. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier). Kay LL; Ronan R; Schaefer EJ; Brewer HB Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810 [TBL] [Abstract][Full Text] [Related]
5. Immunochemical study of the plasma low and high density lipoproteins in Tangier disease. Dumon MF; Visvikis S; Manabe T; Clerc M FEBS Lett; 1986 May; 201(1):163-7. PubMed ID: 3086124 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412 [TBL] [Abstract][Full Text] [Related]
7. Biochemical studies in a patient with a Tangier syndrome. Yao JK; Herbert PN; Fredrickson DS; Ellefson RD; Heinen RJ; Forte T; Dyck PJ J Neuropathol Exp Neurol; 1978; 37(2):138-54. PubMed ID: 632844 [TBL] [Abstract][Full Text] [Related]
8. The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease. Assmann G; Schmitz G; Heckers H Scand J Clin Lab Invest Suppl; 1978; 150():98-102. PubMed ID: 218282 [TBL] [Abstract][Full Text] [Related]
10. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975 [TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency. Sparks DL; Frohlich J; Pritchard PH Clin Chem; 1988 Sep; 34(9):1812-5. PubMed ID: 3416429 [TBL] [Abstract][Full Text] [Related]
12. Lipid transport in the avian species. Part I. Isolation and characterization of apolipoproteins and major lipoprotein density classes of male turkey serum. Kelley JL; Alaupovic P Atherosclerosis; 1976; 24(1-2):155-75. PubMed ID: 182183 [TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase. Assmann G; Herbert PN; Fredrickson DS; Forte T J Clin Invest; 1977 Jul; 60(1):242-52. PubMed ID: 194920 [TBL] [Abstract][Full Text] [Related]
14. Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency. Gustafson A; McConathy WJ; Alaupovic P; Curry MD; Persson B Scand J Clin Lab Invest; 1979 Jun; 39(4):377-87. PubMed ID: 230573 [No Abstract] [Full Text] [Related]
15. Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes. Bar-On H; Roheim PS; Eder HA J Clin Invest; 1976 Mar; 57(3):714-21. PubMed ID: 175093 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia. Alaupovic P; Knight-Gibson C; Wang CS; Downs D; Koren E; Brewer HB; Gregg RE J Lipid Res; 1991 Jan; 32(1):9-19. PubMed ID: 1901345 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
19. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis. Forte TM; Nichols AV; Krauss RM; Norum RA J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564 [TBL] [Abstract][Full Text] [Related]